Abstract
This study sought to clarify the factors associated with the magnitude of the difference between home and office blood pressures in treated hypertensive patients. Study subjects consisted of 3,308 essential hypertensive patients (mean age, 66 years; males, 44%) receiving antihypertensive treatment in primary care settings in Japan. Patients were classified into 3 groups (the home effect group, small difference group, and office effect group) according to tertiles of the magnitude of the office-home systolic blood pressure difference. Compared to the other two groups, the home effect group patients were significantly and independently older, were more often habitual drinkers, had a greater family history of cerebrovascular disease or personal history of ischemic heart disease, and were prescribed a greater number of antihypertensive drugs, non-amlodipine calcium channel blockers, and α-blockers as antihypertensive drugs. Compared to the other two groups, the office effect group patients were significantly and independently younger, included more females, less frequently had a family history of cerebrovascular disease or personal history of ischemic heart disease, and were less often prescribed α-blockers as antihypertensive drugs. The characteristics of home effect group patients and the factors negatively affecting the blood pressure difference were the same. Among treated hypertensive patients, compared to patients in the other groups, office effect group patients had a lower-risk profile, whereas home effect group patients had a higher-risk profile. These predictive factors might be useful clinically to help identify patients who may have a large difference between home and office blood pressures.
Similar content being viewed by others
Article PDF
References
Mancia G, Bertinieri G, Grassi G, et al: Effects of blood-pressure measurement by the doctor on patient’s blood pressure and heart rate. Lancet 1983; 24: 695–698.
Stergiou GS, Efstathiou SP, Argyraki CK, Roussias LG, Mountokalakis TD : White coat effect in treated versus untreated hypertensive individuals: a case-control study using ambulatory and home blood pressure monitoring. Am J Hypertens 2004; 17: 124–128.
Wing LM, Brown MA, Beilin LJ, Ryan P, Reid CM : ‘Reverse white-coat hypertension’ in older hypertensives. J Hypertens 2002; 20: 639–644.
Bombelli M, Sega R, Facchetti R, et al: Prevalence and clinical significance of a greater ambulatory versus office blood pressure (‘reversed white coat’ condition) in a general population. J Hypertens 2005; 23: 513–520.
Pickering TG, Davidson K, Gerin W, Schwartz JE : Masked hypertension. Hypertension 2002; 106: e196–e197.
MacDonald MB, Laing GP, Wilson MP, Wilson TW : Prevalence and predictors of white-coat response in patients with treated hypertension. CMAJ 1999; 161: 265–269.
Niiranen TJ, Jula AM, Kantola IM, Reunanen A : Prevalence and determinants of isolated clinic hypertension in the Finnish population: the Finn-HOME study. J Hypertens 2006; 24: 463–470.
Obara T, Ohkubo T, Funahashi J, et al: Isolated uncontrolled hypertension at home and in the office among treated hypertensive patients from the J-HOME study. J Hypertens 2005; 23: 1653–1660.
Ohkubo T, Obara T, Funahashi J, et al: Control of blood pressure as measured at home and office, and comparison with physicians’ assessment of control among treated hypertensive patients in Japan: first report of the J-HOME study. Hypertens Res 2004; 27: 755–763.
O’Brien E, Asmar R, Beilin L, et al: European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens 2003; 21: 821–848.
Imai Y, Otsuka K, Kawano Y, et al: Japanese Society of Hypertension (JSH) guidelines for self-monitoring of blood pressure at home. Hypertens Res 2003; 26: 771–782.
Shirasaki O, Terada H, Niwano K, et al: The Japan Home-Health Apparatus Industrial Association: investigation of home-use electronic sphygmomanometers. Blood Press Monit 2001; 6: 303–307.
Association for the Advancement of Medical Instrumentation : American National Standard for Electronic or Automated Sphygmomanometers. Washington DC, AAMI Analysis and Review, 1987.
Bobrie G, Genes N, Vaur L, et al: Is “isolated home” hypertension as opposed to “isolated office” hypertension a sign of greater cardiovascular risk? Arch Intern Med 2001; 161: 2205–2211.
Ishikawa J, Kario K, Eguchi K, et al: Regular alcohol drinking is a determinant of masked morning hypertension detected by home blood pressure monitoring in medicated hypertensive patients with well-controlled clinic blood pressure: the Jichi Morning Hypertension Research (J-MORE) study. Hypertens Res 2006; 29: 679–686.
Kawano Y, Abe H, Takishita S, Omae T : Effects of alcohol restriction on 24-hour ambulatory blood pressure in Japanese men with hypertension. Am J Med 1998; 105: 307–311.
Chonan K, Hashimoto J, Ohkubo T, et al: Insufficient duration of action of antihypertensive medications mediates high blood pressure in the morning in hypertensive population: the Ohasama study. Clin Exp Hypertens 2002; 24: 261–275.
Pickering TG, Levenstein M, Walmsley P : Nighttime dosing of doxazosin has peak effect on morning ambulatory blood pressure. Results of the HALT Study. Hypertension and Lipid Trial Study Group. Am J Hypertens 1994; 7: 844–847.
Tomiyama M, Horio T, Kamide K, et al: Reverse white-coat effect as an independent risk for left ventricular concentric hypertrophy in patients with treated essential hypertension. J Hum Hypertens 2007; 21: 212–219.
Kato T, Horio T, Tomiyama M, Kamide K, et al: Reverse white-coat effect as an independent risk for microalbuminuria in treated hypertensive patients. Nephrol Dial Transplant 2007; 22: 911–916.
Hozawa A, Imai Y, Ohkubo T, et al: Prognostic significance of the white coat effect defined as the difference between home and screening blood pressure measurements: the Ohasama study. J Hypertens 1999; 17: S23.
Hozawa A, Ohkubo T, Nagai K, et al: Factors affecting the difference between screening and home blood pressure measurements: the Ohasama Study. J Hypertens 2001; 19: 13–19.
Mallion JM, Clerson P, Bobrie G, et al: Predictive factors for masked hypertension within a population of controlled hypertensives. J Hypertens 2006; 24: 2365–2370.
Myers MG, Reeves RA : White coat effect in treated hypertensive patients: sex differences. J Hum Hypertens 1995; 9: 729–733.
Verdecchia P, Schillaci G, Borgioni C, et al: White coat hypertension and white coat effect. Similarities and differences. Am J Hypertens 1995; 8: 790–798.
Gosse P, Promax H, Durandet P, Clementy J : ‘White coat’ hypertension. No harm for the heart. Hypertension 1993; 22: 766–770.
Schillaci G, Verdecchia P, Boldrini F, et al: The irrelevance of the clinical arterial pressure with respect to outpatient pressure in defining the risk of left ventricular hypertrophy in essential arterial hypertension. G Ital Cardiol 1991; 21: 651–659.
Penzo M, Guzzardi G, Palatini P : Relationship between blood pressure determination anxiety and hypertensive complications. Cardiologia 1995; 40: 117–122.
Nakashima T, Yamano S, Sasaki R, et al: White-coat hypertension contributes to the presence of carotid arteriosclerosis. Hypertens Res 2004; 27: 739–745.
Conen D, Dieterle T, Utech K, et al: C-reactive protein and B-type natriuretic peptides in never-treated white coat hypertensives. Hypertens Res 2006; 29: 411–415.
Leary AC, Donnan PT, MacDonald TM, Murphy MB : The white-coat effect is associated with increased blood pressure reactivity to physical activity. Blood Press Monit 2002; 7: 209–213.
Ugajin T, Hozawa A, Ohkubo T, et al: White-coat hypertension as a risk factor for the development of home hypertension. Arch Intern Med 2005; 165: 1541–1546.
Verdecchia P, Reboldi GP, Angeli F, et al: Short- and long-term incidence of stroke in white-coat hypertension. Hypertension 2005; 45: 203–208.
Mancia G : Methods for assessing blood pressure values in humans. Hypertension 1983; 5: III5–III13.
Author information
Authors and Affiliations
Consortia
Corresponding author
Rights and permissions
About this article
Cite this article
Horikawa, T., Obara, T., Ohkubo, T. et al. Difference between Home and Office Blood Pressures among Treated Hypertensive Patients from the Japan Home versus Office Blood Pressure Measurement Evaluation (J-HOME) Study. Hypertens Res 31, 1115–1123 (2008). https://doi.org/10.1291/hypres.31.1115
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1291/hypres.31.1115
Keywords
This article is cited by
-
The long-term reproducibility of the white-coat effect on blood pressure as a continuous variable from the Ohasama Study
Scientific Reports (2023)
-
Differences between home blood pressure and strictly measured office blood pressure and their determinants in Japanese men
Hypertension Research (2021)
-
Blood pressure differences between office and home settings among Japanese normotensive subjects and hypertensive patients
Hypertension Research (2017)
-
Differences between clinic blood pressure and morning home blood pressure, as shown by Bland–Altman plots, in a large observational study (HONEST study)
Hypertension Research (2015)
-
Parity as a factor affecting the white-coat effect in pregnant women: the BOSHI study
Hypertension Research (2015)